517 related articles for article (PubMed ID: 27558562)
1. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway.
Olesen ET; Moeller HB; Assentoft M; MacAulay N; Fenton RA
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F935-F944. PubMed ID: 27558562
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
Olesen ET; Rützler MR; Moeller HB; Praetorius HA; Fenton RA
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12949-54. PubMed ID: 21768374
[TBL] [Abstract][Full Text] [Related]
3. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking.
Li C; Wang W; Rivard CJ; Lanaspa MA; Summer S; Schrier RW
Am J Physiol Renal Physiol; 2011 May; 300(5):F1255-61. PubMed ID: 21325494
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-2 membrane targeting: still a conundrum.
Olesen ET; Fenton RA
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F744-F747. PubMed ID: 28179252
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor/cAMP/protein kinase A signaling in inner medullary collecting duct cells.
Kim S; Jo CH; Kim GH
Am J Physiol Renal Physiol; 2021 May; 320(5):F963-F971. PubMed ID: 33843270
[TBL] [Abstract][Full Text] [Related]
8. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.
Huang J; Montani JP; Verrey F; Feraille E; Ming XF; Yang Z
FASEB J; 2018 Oct; 32(10):5520-5531. PubMed ID: 29718707
[TBL] [Abstract][Full Text] [Related]
9. An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons.
Hayashi Y; Morinaga S; Liu X; Zhang J; Wu Z; Yokoyama T; Nakanishi H
Mediators Inflamm; 2016; 2016():5079597. PubMed ID: 27298516
[TBL] [Abstract][Full Text] [Related]
10. In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac.
Kortenoeven ML; Trimpert C; van den Brand M; Li Y; Wetzels JF; Deen PM
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1395-401. PubMed ID: 22419689
[TBL] [Abstract][Full Text] [Related]
11. Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells.
Di Mise A; Venneri M; Ranieri M; Centrone M; Pellegrini L; Tamma G; Valenti G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888044
[TBL] [Abstract][Full Text] [Related]
12. The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.
Tamma G; Di Mise A; Ranieri M; Geller A; Tamma R; Zallone A; Valenti G
J Cell Mol Med; 2017 Sep; 21(9):1767-1780. PubMed ID: 28326667
[TBL] [Abstract][Full Text] [Related]
13. Extracellular pH affects phosphorylation and intracellular trafficking of AQP2 in inner medullary collecting duct cells.
Choi HJ; Jung HJ; Kwon TH
Am J Physiol Renal Physiol; 2015 Apr; 308(7):F737-48. PubMed ID: 25651562
[TBL] [Abstract][Full Text] [Related]
14. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor.
Lee YJ; Song IK; Jang KJ; Nielsen J; Frøkiaer J; Nielsen S; Kwon TH
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F340-50. PubMed ID: 16896188
[TBL] [Abstract][Full Text] [Related]
15. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases.
Olesen ETB; Fenton RA
Nat Rev Nephrol; 2021 Nov; 17(11):765-781. PubMed ID: 34211154
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.
Bouley R; Hawthorn G; Russo LM; Lin HY; Ausiello DA; Brown D
Biol Cell; 2006 Apr; 98(4):215-32. PubMed ID: 16563128
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
Elberg D; Turman MA; Pullen N; Elberg G
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):11-6. PubMed ID: 22503965
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.
Vleeshouwers W; van den Dries K; de Keijzer S; Joosten B; Lidke DS; Cambi A
Front Immunol; 2020; 11():613286. PubMed ID: 33643295
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Echeverria V; Clerman A; Doré S
Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
